Skip to main content

Day: September 26, 2024

Humacyte to Host Virtual KOL Event to Discuss Case Studies on the Use of Acellular Tissue Engineered Vessel (ATEV™) in Vascular Trauma Treatment on September 30, 2024

DURHAM, N.C., Sept. 26, 2024 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced it will host a virtual KOL event on Monday, September 30, 2024 at 8:00 AM ET. To register, click here. The event will feature Charles Fox, MD (University of Maryland School of Medicine), Rishi Kundi MD, RPVI, FACS, FSVS (University of Maryland School of Medicine), and YingWei Lum, MD, MPH (Johns Hopkins School of Medicine), who will discuss the unmet medical need and current treatment landscape for urgent arterial repair after extremity vascular trauma. The event will highlight case studies evaluating Humacyte’s acellular tissue engineered vessel (ATEV) product candidate as a treatment for vascular...

Continue reading

Stella-Jones Announces Private Offering of C$400 Million of 7-Year Senior Unsecured Notes

MONTREAL, Sept. 26, 2024 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) announced today that it has priced an inaugural offering of Canadian dollar denominated senior unsecured notes. Stella-Jones will issue C$400 million aggregate principal amount of senior unsecured notes due October 1st, 2031, bearing interest at the rate of 4.312% per annum, payable semi-annually until maturity (the “Notes”). The Company intends to use the net proceeds from the offering to repay existing indebtedness under its revolving credit facilities, and any balance will be used for general corporate purposes. The Notes are being offered in Canada through an agency syndicate consisting of TD Securities Inc., CIBC World Markets Inc. and RBC Dominion Securities Inc., as joint lead agents and bookrunners, along with Merrill...

Continue reading

Grupo Aeroportuario del Pacifico Announces Credit Line Refinancing for USD$40.0 Million

GUADALAJARA, Mexico, Sept. 26, 2024 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces it has completed the refinancing of the credit facility that matured today with Banco Nacional de México, S.A., (“Citibanamex”) for USD$40.0 million, extending the maturity by 6 additional months. The interest will be payable monthly at a variable rate of SOFR plus 25 basis points, without fees, and principal payment on March 21, 2025. Company Description Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (GAP) operates 12 airports throughout Mexico’s Pacific region, including the major cities of Guadalajara and Tijuana, the four tourist destinations of Puerto Vallarta, Los Cabos, La Paz and Manzanillo, and six other mid-sized cities: Hermosillo, Guanajuato, Morelia, Aguascalientes,...

Continue reading

Streamline Health® Announces 1-For-15 Reverse Stock Split

ATLANTA, Sept. 26, 2024 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, today announced that it will proceed with a 1-for-15 reverse stock split (the “Reverse Stock Split”) of its outstanding shares of Common Stock (the “Common Stock”) following approval by its Board of Directors. The 1-for-15 ratio is within the range approved by the Company’s stockholders at the Special Meeting of Stockholders held on September 19, 2024. The Reverse Stock Split is intended to bring the Company into compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The Reverse Stock Split is expected to become effective at 12:01 a.m., Eastern Daylight Time, on...

Continue reading

Verizon to support Florida and Georgia communities affected by Hurricane Helene Call/Text/Data usage incurred by customers in hardest hit counties will be waived from Sept. 26-Oct. 5

For media: Regular updates can be found here. What you need to know:Verizon to waive domestic call, text, and data usage for postpaid consumer, small business customers,* and Verizon Prepaid customers impacted by the storm in parts of Florida and Georgia from Sept. 26-Oct. 5, 2024. For prepaid customers using Straight Talk, Tracfone, Total Wireless, Simple Mobile, Walmart Family Mobile, Net10, GoSmart, and Page Plus, we will extend service end dates to Oct. 5, 2024. With year-round preparedness, hardened network infrastructure, and an extensive fleet of mobile assets, Verizon’s networks are primed for Hurricane Helene.ALPHARETTA, Ga., Sept. 26, 2024 (GLOBE NEWSWIRE) — To help residents in Florida and Georgia expected to be impacted by Hurricane Helene, Verizon will waive postpaid domestic call/text/data usage from Sept. 26-Oct....

Continue reading

Qualigen Therapeutics, Inc. Announces management changes.

CARLSBAD, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced on September 23, 2024, Mr. Michael Poirier, notified the board of directors of the Company (the Board”) of his intention to resign as chief executive officer and Chairman of the Board of the Company, effective immediately. On the same date, Mr. Christopher Lotz, Chief Financial Office also tendered his resignation from the company, effective immediately. Both resignations were attributed to disagreements with the Company regarding its future direction and strategic initiatives. On September 25, 2024, the board of directors appointed Campbell Becher as President of the Company, effective immediately. On September 26, 2024, the board of directors appointed Kevin Richardson as Interim Chief Executive Officer...

Continue reading

CURRENC Rings Nasdaq Closing Bell in Honor of Listing

NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) — CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech and digital remittance pioneer serving millions of unbanked and underbanked individuals in Southeast Asia and beyond, today announced that the Company’s management celebrated its recent listing with a Closing Bell Ceremony at Nasdaq MarketSite in Times Square this afternoon. CURRENC began trading on the Nasdaq on September 3, 2024, after completing its business combination with INFINT Acquisition Corporation (formerly NYSE: IFIN), which was facilitated by ARC Group Limited. “Over the past decade, our digital remittance business has experienced rapid growth in both network coverage and total processing value, a testament to our team’s dedication and our customers’ trust,” said Alex Kong, Founder and Executive Chairman...

Continue reading

Dundee Corporation Announces the Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 Million

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A) (the “Company” or “Dundee”) announced today that it has sold to a private investor 8,000 of the 1,015,008 shares it holds in TauRX Pharmaceuticals Ltd. (“TauRx”) at a price of US$125 per share for proceeds to the Company of US$1,000,000. The transaction remains subject to TauRx board approval. Following the completion of the transaction Dundee will continue to hold 1,007,008 TauRx shares. ABOUT DUNDEE CORPORATION Dundee Corporation is a public Canadian independent holding company, listed on the Toronto Stock Exchange under the symbol “DC.A”. Through its operating subsidiaries, Dundee Corporation is an active investor focused on delivering long-term, sustainable value as a trusted partner in the mining sector with more than 30 years of experience making accretive...

Continue reading

Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update

-Positive 90-day and 180-day Interim Clinical Trial Data for the First Oculopharyngeal Muscular Dystrophy (OPMD) Subject Dosed with the Low-Dose of BB-301 in the Phase 1b/2a Clinical Treatment Study Reported in April and July- -Second Subject Dosed with the Low-Dose of BB-301 in February 2024, and Third Subject Expected to Receive the Low-Dose of BB-301 in Calendar Quarter Four of 2024- –Closed an Oversubscribed Private Placement Financing of $40.0 Million on April 22nd, Cash Runway Extended Through 2025– HAYWARD, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today...

Continue reading

Crediciorp Ltd.: Credicorp Highlights Growth Initiatives Driven by Innovation Strategy and Positive Outlook at the 2024 Strategic Update

On track to Achieve Sustainable 18% ROE Sets More Aggressive 2026 Aspirations for Yape Lima, Sept. 26, 2024 (GLOBE NEWSWIRE) — Lima, PERU, September 26, 2024 — Credicorp Ltd. today hosted its 2024 Strategic Update during which senior management outlined how the Company is powering sustainable growth through innovation, its goals and disciplined approach to digital disruption initiatives and the milestones achieved. Management also discussed the pipeline of future projects and how initiatives are serving to decouple its results from macroeconomic trends. Key highlights from the event include a reaffirmation of Credicorp’s commitment to innovation and self-disruption, market expansion, and shareholder value creation summarized below: Backed by strong performance across most of the Lines of Business, Credicorp remains on track...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.